BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 20811062)

  • 101. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.
    Pease ME; McKinnon SJ; Quigley HA; Kerrigan-Baumrind LA; Zack DJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):764-74. PubMed ID: 10711692
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent.
    Bakalash S; Kipnis J; Yoles E; Schwartz M
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2648-53. PubMed ID: 12147598
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.
    Prokosch V; Schallenberg M; Thanos S
    PLoS One; 2013; 8(2):e49730. PubMed ID: 23468831
    [TBL] [Abstract][Full Text] [Related]  

  • 104. DBA/2J mice are susceptible to diabetic nephropathy and diabetic exacerbation of IOP elevation.
    Soto I; Howell GR; John CW; Kief JL; Libby RT; John SW
    PLoS One; 2014; 9(9):e107291. PubMed ID: 25207540
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Autophagy in the Aging and Experimental Ocular Hypertensive Mouse Model.
    Nettesheim A; Dixon A; Shim MS; Coyne A; Walsh M; Liton PB
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):31. PubMed ID: 32797200
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy.
    Nickells RW; Howell GR; Soto I; John SW
    Annu Rev Neurosci; 2012; 35():153-79. PubMed ID: 22524788
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Alterations of the synapse of the inner retinal layers after chronic intraocular pressure elevation in glaucoma animal model.
    Park HY; Kim JH; Park CK
    Mol Brain; 2014 Aug; 7():53. PubMed ID: 25116810
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1.
    Zhu Y; Zhang L; Sasaki Y; Milbrandt J; Gidday JM
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):25-36. PubMed ID: 23211826
    [TBL] [Abstract][Full Text] [Related]  

  • 109. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
    Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
    J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension.
    Kompass KS; Agapova OA; Li W; Kaufman PL; Rasmussen CA; Hernandez MR
    BMC Neurosci; 2008 Sep; 9():93. PubMed ID: 18822132
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Heparan sulfate regulates intraretinal axon pathfinding by retinal ganglion cells.
    Ogata-Iwao M; Inatani M; Iwao K; Takihara Y; Nakaishi-Fukuchi Y; Irie F; Sato S; Furukawa T; Yamaguchi Y; Tanihara H
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6671-9. PubMed ID: 21743013
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
    Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
    Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model.
    Steinhart MR; Cone FE; Nguyen C; Nguyen TD; Pease ME; Puk O; Graw J; Oglesby EN; Quigley HA
    Mol Vis; 2012; 18():1093-106. PubMed ID: 22701298
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension.
    Kim ML; Sung KR; Kwon J; Choi GW; Shin JA
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830387
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Elevated intraocular pressure causes inner retinal dysfunction before cell loss in a mouse model of experimental glaucoma.
    Frankfort BJ; Khan AK; Tse DY; Chung I; Pang JJ; Yang Z; Gross RL; Wu SM
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):762-70. PubMed ID: 23221072
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model.
    Abdul Y; Akhter N; Husain S
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1816-28. PubMed ID: 23404122
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection.
    Ward NJ; Ho KW; Lambert WS; Weitlauf C; Calkins DJ
    J Neurosci; 2014 Feb; 34(9):3161-70. PubMed ID: 24573275
    [TBL] [Abstract][Full Text] [Related]  

  • 118. BCLX
    Donahue RJ; Fehrman RL; Gustafson JR; Nickells RW
    Cell Death Dis; 2021 Aug; 12(8):781. PubMed ID: 34376637
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Critical pathogenic events underlying progression of neurodegeneration in glaucoma.
    Calkins DJ
    Prog Retin Eye Res; 2012 Nov; 31(6):702-19. PubMed ID: 22871543
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Retinal gene expression changes related to IOP exposure and axonal loss in DBA/2J mice.
    Panagis L; Zhao X; Ge Y; Ren L; Mittag TW; Danias J
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7807-16. PubMed ID: 21908583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.